New FDA warnings on NSAIDs and COX-2s are causing a return to basics for pain management
New FDA warnings on NSAIDs and COX-2s are causing a return to basics for pain management.
All Rx NSAIDs will have a new boxed warning about GI and cardiovascular risk. Patients will get a new Medication Guide when they fill their prescriptions.
Celebrex (celecoxib) will have a Medication Guide, plus a boxed warning, plus clinical trial data on cardiovascular risk.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote